This inventor holds 2 USPTO granted patents. Top assignee: Other. Active years: 1978-1979.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Shiraoka, JA (1978)
- Shiraoka, JP (1979)
Company Filing History:
Years Active: 1978-1979
Title: Tomoya Machinami: Innovator in Pharmaceutical Chemistry
Introduction
Tomoya Machinami is a notable inventor based in Shiraoka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on nitrosourea derivatives. With a total of 2 patents, his research focuses on developing compounds that exhibit high inhibitory activity against leukemia and tumors while maintaining low toxicity.
Latest Patents
Machinami's latest patents include groundbreaking work on nitrosourea derivatives. These new compounds are designed to possess a high inhibitory activity against leukemia and tumors, making them valuable for pharmaceutical applications. The compounds are characterized by specific formulas where A represents various glycosyl groups or residues, and R denotes lower alkyl or halo-alkyl groups. This innovative approach is aimed at enhancing the efficacy and safety of cancer treatments.
Career Highlights
Throughout his career, Tomoya Machinami has demonstrated a commitment to advancing medical science through his inventions. His work has not only contributed to the understanding of nitrosourea derivatives but has also paved the way for new therapeutic options in oncology. His dedication to research and development has established him as a respected figure in the pharmaceutical industry.
Collaborations
Machinami has collaborated with esteemed colleagues such as Tetsuo Suami and Takashi Hisamatsu. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of their research.
Conclusion
In summary, Tomoya Machinami is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in cancer treatment. His innovative patents and collaborative efforts highlight his dedication to improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile